H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs Perficient, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
Perficient, Inc.
MORank #199FEIN 74-2853258

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPPerficient, Inc.
Total filings80,8132,691
Certified %98.23%95.80%
Denied %1.09%1.26%
Withdrawn %0.61%1.78%
Cert-withdrawn %0.07%1.15%
Rank#4#199
Active yearsFY2010–FY2026FY2010–FY2026
Worksite statePAMO

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — Perficient, Inc.

DOL case-status mix.

Outcome breakdown: Certified 95.8%, Cert-withdrawn 1.2%, Withdrawn 1.8%, Denied 1.3%
Outcome breakdown
OutcomeShare
Certified95.8%
Cert-withdrawn1.2%
Withdrawn1.8%
Denied1.3%
Certified95.8%
Cert-withdrawn1.2%
Withdrawn1.8%
Denied1.3%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
Perficient, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY2010130
FY2011157
FY2012198
FY2013220
FY2014252
FY2015269
FY2016270
FY2017216
FY2018228
FY2019261
FY20200
FY20210
FY20220
FY202347
FY2024149
FY2025154
FY2026140

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — Perficient, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.